Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic.

ADHD Adolescents COVID-19 Children European ADHD Guidelines Group (EAGG) Pandemic Remote assessment

Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 14 06 2022
accepted: 19 01 2023
medline: 22 5 2023
pubmed: 11 2 2023
entrez: 10 2 2023
Statut: ppublish

Résumé

The COVID-19 pandemic led ADHD services to modify the clinical practice to reduce in-person contact as much as possible to minimise viral spread. This had far-reaching effects on day-to-day clinical practice as remote assessments were widely adopted. Despite the attenuation of the acute threat from COVID, many clinical services are retaining some remote practices. The lack of clear evidence-based guidance about the most appropriate way to conduct remote assessments meant that these changes were typically implemented in a localised, ad hoc, and un-coordinated way. Here, the European ADHD Guidelines Group (EAGG) discusses the strengths and weaknesses of remote assessment methods of children and adolescents with ADHD in a narrative review based on available data and expert opinions to highlight key recommendations for future studies and clinical practice. We conclude that going forward, despite remote working in clinical services functioning adequately during the pandemic, all required components of ADHD assessment should still be completed following national/international guidelines; however, the process may need adaptation. Social restrictions, including changes in education provision, can either mask or exacerbate features associated with ADHD and therefore assessment should carefully chart symptom profile and impairment prior to, as well as during an ongoing pandemic. While remote assessments are valuable in allowing clinical services to continue despite restrictions and may have benefits for routine care in the post-pandemic world, particular attention must be paid to those who may be at high risk but not be able to use/access remote technologies and prioritize these groups for conventional face-to-face assessments.

Identifiants

pubmed: 36764972
doi: 10.1007/s00787-023-02148-1
pii: 10.1007/s00787-023-02148-1
pmc: PMC9918404
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

921-935

Informations de copyright

© 2023. The Author(s).

Références

J Abnorm Child Psychol. 2017 Jan;45(1):27-43
pubmed: 27117555
Neurosci Biobehav Rev. 2021 Sep;128:789-818
pubmed: 33549739
Psychiatry Res. 2021 Feb;296:113692
pubmed: 33421841
J Neurosci Rural Pract. 2021 Jan;12(1):71-79
pubmed: 33531763
PLoS One. 2021 Mar 25;16(3):e0249237
pubmed: 33765076
J Child Psychol Psychiatry. 2010 Apr;51(4):368-89
pubmed: 20015192
J Am Acad Child Adolesc Psychiatry. 2022 Aug;61(8):982-996
pubmed: 34958872
J Child Psychol Psychiatry. 2018 Dec;59(12):1298-1308
pubmed: 29700813
Lancet Child Adolesc Health. 2020 Jun;4(6):e15
pubmed: 32405517
Lancet Psychiatry. 2018 Feb;5(2):175-186
pubmed: 29033005
Encephale. 2020 Jun;46(3S):S85-S92
pubmed: 32522407
J Am Acad Child Adolesc Psychiatry. 2021 Jan;60(1):1-2
pubmed: 33186710
J Clin Sleep Med. 2021 Sep 1;17(9):1759-1765
pubmed: 33792536
Paediatr Child Health. 2021 May 27;26(5):e199-e207
pubmed: 34326910
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Child Adolesc Psychopharmacol. 2016 Oct;26(8):662-671
pubmed: 26258927
N Engl J Med. 2020 Sep 10;383(11):1050-1056
pubmed: 32905677
JAMA Pediatr. 2021 Nov 1;175(11):1142-1150
pubmed: 34369987
J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):263-74
pubmed: 25791143
Int J Environ Res Public Health. 2020 Nov 16;17(22):
pubmed: 33207689
Ir J Psychol Med. 2020 Sep;37(3):204-211
pubmed: 32434606
J Child Adolesc Psychopharmacol. 2020 Jun;30(5):280-284
pubmed: 32515992
J Adolesc Health. 2020 Dec;67(6):769-777
pubmed: 33069580
J Youth Adolesc. 2021 Jan;50(1):44-57
pubmed: 33108542
J Child Psychol Psychiatry. 2021 Dec;62(12):1375-1378
pubmed: 34806768
J Atten Disord. 2022 Jul;26(9):1223-1234
pubmed: 34920689
Am J Psychiatry. 2007 Jun;164(6):942-8
pubmed: 17541055
Public Health. 2021 Jul;196:101-106
pubmed: 34171615
J Am Acad Child Adolesc Psychiatry. 2021 Apr;60(4):513-523
pubmed: 33359408
J Glob Health. 2021 Feb 11;11:04009
pubmed: 33692893
Indian J Psychiatry. 2022 Jan-Feb;64(1):93-97
pubmed: 35400742
Curr Probl Pediatr Adolesc Health Care. 2021 Jan;51(1):100949
pubmed: 33436319
Res Dev Disabil. 2021 Jul;114:103983
pubmed: 33964709
J Child Adolesc Psychopharmacol. 2017 Aug;27(6):546-554
pubmed: 27607909
Lancet Psychiatry. 2020 Oct;7(10):875-882
pubmed: 32593341
Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I7-30
pubmed: 15322953
J Child Psychol Psychiatry. 2021 Sep;62(9):1132-1139
pubmed: 33543486
Br J Psychiatry. 2018 Sep;213(3):526-534
pubmed: 29957167
J Psychiatr Res. 2021 Apr;136:190-197
pubmed: 33610946
J Atten Disord. 2018 Sep;22(11):1074-1080
pubmed: 26224575
J Telemed Telecare. 2021 Oct 11;:1357633X211045186
pubmed: 34633251
J Child Adolesc Behav. 2015;3(5):240
pubmed: 32953987
Telemed J E Health. 2018 Nov;24(11):827-832
pubmed: 30358514
J Atten Disord. 2022 Feb;26(4):549-562
pubmed: 33331195
J Multimorb Comorb. 2022 Apr 23;12:26335565221096977
pubmed: 35586033
BMC Psychiatry. 2017 Feb 10;17(1):66
pubmed: 28183284
J Child Psychol Psychiatry. 2009 Apr;50(4):460-70
pubmed: 19338629
J Child Psychol Psychiatry. 2021 Dec;62(12):1391-1401
pubmed: 34327726
Int J Environ Res Public Health. 2021 Mar 26;18(7):
pubmed: 33810225
Iran J Psychiatry. 2022 Jan;17(1):110-117
pubmed: 35480135
Eur Child Adolesc Psychiatry. 2022 Apr;31(4):649-661
pubmed: 33415470
Br J Psychiatry. 2004 Jan;184:74-8
pubmed: 14702231
JCPP Adv. 2021 Apr;1(1):e12009
pubmed: 34485988
Eur Child Adolesc Psychiatry. 2021 Oct 22;:
pubmed: 34677682
BMJ Open. 2020 Jun 23;10(6):e033324
pubmed: 32580979
J Atten Disord. 2022 Feb;26(4):491-501
pubmed: 33797281
Lancet Psychiatry. 2021 Sep;8(9):774-783
pubmed: 34242595
Brain Behav Immun. 2020 Aug;88:71-74
pubmed: 32561222
Psychol Serv. 2012 Aug;9(3):293-7
pubmed: 22867121
Lancet Child Adolesc Health. 2020 Jun;4(6):412-414
pubmed: 32311314
J Trop Pediatr. 2021 Jan 29;67(1):
pubmed: 33367907

Auteurs

P Santosh (P)

Department of Child and Adolescent Psychiatry, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, UK. paramala.1.santosh@kcl.ac.uk.
Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK. paramala.1.santosh@kcl.ac.uk.
HealthTracker Ltd, Gillingham, Kent, UK. paramala.1.santosh@kcl.ac.uk.

S Cortese (S)

Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.
Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK.
Solent NHS Trust, Southampton, UK.
Hassenfeld Children's Hospital at NYU Langone, New York University Child Study Center, New York City, NY, USA.
Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.

C Hollis (C)

School of Medicine, National Institute for Health Research (NIHR) MindTech Mental Health MedTech Cooperative, NIHR Nottingham Biomedical Research Centre, Institute of Mental Health, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK.

S Bölte (S)

Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Child and Adolescent Psychiatry, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Curtin Autism Research Group, Curtin School of Allied Health, Curtin University, Perth, WA, Australia.

D Daley (D)

NTU Psychology, School of Social Science, Nottingham Trent University, Nottingham, UK.

D Coghill (D)

Departments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, VIC, Australia.
Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Royal Children's Hospital, Melbourne, Melbourne, VIC, Australia.

M Holtmann (M)

LWL-University Hospital for Child and Adolescent Psychiatry, Ruhr University, Bochum, Germany.

E J S Sonuga-Barke (EJS)

Department of Child and Adolescent Psychiatry, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, UK.
Department of Child and Adolescent Psychiatry, Aarhus University, Aarhus, Denmark.

J Buitelaar (J)

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and BehaviourRadboudumc, Nijmegen, The Netherlands.
Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands.

T Banaschewski (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty, Central Institute of Mental Health, Mannheim/Heidelberg University, Mannheim, Germany.

A Stringaris (A)

Divisions of Psychiatry and Psychology and Language Sciences, University College London, London, UK.
First Department of Psychiatry, Aigineteion Hospital, National and Kapodistrian University of Athens, Athens, Greece.

M Döpfner (M)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
School of Child and Adolescent Cognitive Behavior Therapy (AKiP), Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.

S Van der Oord (S)

Clinical Psychology, KU Leuven, Louvain, Belgium.

S Carucci (S)

Department of Biomedical Sciences, Sect. Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
Child and Adolescent Neuropsychiatry Unit, "A. Cao" Paediatric Hospital, ASL Cagliari, Cagliari, Italy.

D Brandeis (D)

Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty, Central Institute of Mental Health, Mannheim/Heidelberg University, Mannheim, Germany.
Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.
Neuroscience Center Zurich, University of Zurich, Zurich, Switzerland.
ETH Zurich, Zurich, Switzerland.

P Nagy (P)

Bethesda Children's Hospital, Budapest, Hungary.

M Ferrin (M)

Barnet, Enfield and Haringey NHS Trust, ReCognition Health, London, UK.

D Baeyens (D)

Clinical Psychology, KU Leuven, Louvain, Belgium.

B J van den Hoofdakker (BJ)

Department of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Clinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, The Netherlands.
Accare Child Study Center, Groningen, The Netherlands.

D Purper-Ouakil (D)

Unit of Child and Adolescent Psychiatry (MPEA1), CHU Montpellier-Saint Eloi Hospital, University of Montpellier, 80 Avenue Augustin Fliche, 34000, Montpellier, France.
Team Psychiatry, Development and Trajectories, INSERM CESP U 1018, University Paris Saclay, Gif-sur-Yvette, France.

A Ramos-Quiroga (A)

Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

M Romanos (M)

Department of Child and Adolescent, Center of Mental Health, University Hospital of Wurzburg, Wurzburg, Germany.

C A Soutullo (CA)

Louis A Faillace Department of Psychiatry and Behavioral Science, University of Texas (UT) Health, Houston, TX, USA.

A Thapar (A)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Wolfson Centre for Young People's Mental Health, Cardiff University School of Medicine, Wales, UK.

I C K Wong (ICK)

Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, SAR, China.
Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.

A Zuddas (A)

Department of Biomedical Sciences, Sect. Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
Child and Adolescent Neuropsychiatry Unit, "A. Cao" Paediatric Hospital, ASL Cagliari, Cagliari, Italy.

C Galera (C)

University of Bordeaux, Bordeaux, France.
Bordeaux Population Health Centre, INSERM U1219, Bordeaux, France.
Child and Adolescent Psychiatry Department, Charles Perrens Hospital, Bordeaux, France.

E Simonoff (E)

Department of Child and Adolescent Psychiatry, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH